Diabetes

Diabetes drugs may help older adults slow frailty

A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors—such as empagliflozin (Jardiance) and dapagliflozin (Farxiga)—or glucagon-like peptide-1 ...

Alzheimer's disease & dementia

Common health conditions can influence Alzheimer's blood tests

How do everyday health issues affect new blood tests for Alzheimer's disease? A study from Karolinska Institutet, published in Alzheimer's & Dementia, suggests that factors like kidney function, cholesterol, and diabetes ...

Dentistry

The largest open dataset of deciduous teeth in Spain

The Centro Nacional de Investigación sobre la Evolución Humana (CENIEH) has published a valuable dataset comprising 712 measurements of deciduous teeth from 52 Spanish children belonging to the renowned Ratón Pérez Collection. ...

Medications

Study finds people on colchicine need less joint replacement

Gout is the most common form of inflammatory arthritis, with a worldwide prevalence of approximately 4%. The accumulation of monosodium urate crystals in gout leads to the clinical manifestations of the disease and, if left ...

Medications

GLP-1RAs shown to reduce risk of cardiovascular death

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide, liraglutide, and tirzepatide are widely prescribed both for Type 2 diabetes and weight loss. These drugs also have shown promise in clinical trials ...

Diseases, Conditions, Syndromes

WHO warns of increase in malaria cases and deaths

Deaths linked to malaria last year rose last year, the World Health Organization said on Thursday, warning also of an increase in cases and resistance to current treatment.

page 28 from 40